Back to Fayez Sarofim & Co. Fayez Sarofim & Co.

ABBV

Showing 9 of 32 quarters

Position history for Fayez Sarofim & Co.Fayez Sarofim & Co.'s holdings in AbbVie Inc.

Yes. Fayez Sarofim holds 2,762,173 shares of ABBV (AbbVie), worth $722.5M, as of its Q3 2026 13F filing. It reduced the position by 114,612 shares (-4.0%) from Q2 2026. Fayez Sarofim has held ABBV in every 13F on record since Q4 2018, 32 quarterly filings. ABBV is 1.7% of Fayez Sarofim's reported 13F portfolio.

Current Value

$722.5M

Current Shares

2.8M

Total Value Change

+$317.1M

Total Shares Change

+709,279

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
2.8M
-4.0%
$722.5M1.7%$259.99
0
2026-Q2
Increased
2.9M
+4.4%
$723.9M1.7%$248.34
52
2026-Q1
Increased
2.8M
+6.7%
$599.5M1.5%$212.87
53
2025-Q4
Increased
2.6M
+19.5%
$590.5M1.4%$221.85
59
2025-Q3
Decreased
2.2M
-0.2%
$500.9M1.2%$223.20
0
2025-Q2
Increased
2.2M
+0.1%
$402.4M1.0%$177.40
44
2025-Q1
Decreased
2.2M
-1.8%
$453.9M1.1%$198.41
0
2024-Q4
Increased
2.2M
+7.5%
$392M1.0%$166.71
47
2024-Q3
Increased
2.1M
+1.2%
$405.4M1.0%$183.80
50

Other major holders of ABBV: Vanguard Group Inc., BlackRock, Inc.

Optional analytics helps us improve. How it’s used